BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6194223)

  • 1. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
    Jaffe CL; McMahon-Pratt D
    J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
    Jaffe CL; Bennett E; Grimaldi G; McMahon-Pratt D
    J Immunol; 1984 Jul; 133(1):440-7. PubMed ID: 6373932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
    Pan AA; McMahon-Pratt D
    J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific antibodies to Leishmania tropica (minor) recognize somatic antigens and exometabolites.
    Jaffe CL; Sarfstein R
    J Immunol; 1987 Aug; 139(4):1310-9. PubMed ID: 3302043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
    Pratt DM; Bennett E; Grimaldi G; Jaffe CL
    J Immunol; 1985 Mar; 134(3):1935-40. PubMed ID: 2578524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species and stage specificity of Leishmania donovani antigens.
    White AC; Hanham C
    J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location.
    de Ibarra AA; Howard JG; Snary D
    Parasitology; 1982 Dec; 85 (Pt 3)():523-31. PubMed ID: 6184664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
    Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
    East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.
    Kirchhoff LV; Hieny S; Shiver GM; Snary D; Sher A
    J Immunol; 1984 Nov; 133(5):2731-5. PubMed ID: 6207242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.
    Kweider M; Lemesre JL; Darcy F; Kusnierz JP; Capron A; Santoro F
    J Immunol; 1987 Jan; 138(1):299-305. PubMed ID: 3782801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Leishmania (Viannia) braziliensis glycolipid antigens and their reactivity with mAb SST-1, specific for parasites of Viannia subgenus.
    Silveira TG; Yoneyama KA; Takahashi HK; Straus AH
    Parasitology; 2005 Dec; 131(Pt 6):737-45. PubMed ID: 16336727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies.
    Handman E; Hocking RE
    Infect Immun; 1982 Jul; 37(1):28-33. PubMed ID: 6179879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
    Howard JG; Liew FY; Hale C; Nicklin S
    J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies that react with Leishmania (Viannia) naiffi.
    Hanham CA; Shaw JJ; Lainson R
    J Parasitol; 1991 Oct; 77(5):680-7. PubMed ID: 1919913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-induced modulation of Leishmania donovani surface membrane antigens.
    Dwyer DM
    J Immunol; 1976 Dec; 117(6):2081-91. PubMed ID: 792338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid.
    Sacks DL; da Silva RP
    J Immunol; 1987 Nov; 139(9):3099-106. PubMed ID: 3312412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.